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Pemphigoid Gestationis: A Rare Dermatosis of 
Pregnancy
Victoria Tran, MS3 and Meghan Belamorich, MD
INTRODUCTION
Pemphigoid gestationis is a rare dermatosis of pregnancy 
that often goes unrecognized or misdiagnosed. It can 
lead to adverse fetal outcomes including preterm delivery, 
low fetal birth weight, and even neonatal pemphigoid 
gestationis1. As such, proper diagnosis and management 
is critical in reducing fetal risk. 
CASE PRESENTATION
A 23 year-old Hispanic G4P2103 woman at 36 weeks and 
5 days of gestation presented to the emergency 
department with a bullous rash associated with pruritus 
and erythema of 1 month duration. The rash started with 
a few small pruritic and painful vesicles around her 
umbilicus that spread to the rest of her abdomen, legs, 
and arms and coalesced to become bullae (Figures 1,2). 
Her chest and back had a pruritic, erythematous rash 
without bullae (Figure 3), but her fatce, hands, feet, and 
oral mucosa were spared. 
The patient was initially diagnosed with herpes by her 
outpatient provider and was prescribed valacyclovir, but 
noted no improvement in her symptoms. Subsequently, 
she was thought to have a bullous disease and given a 
methylprednisolone dose pack. While the patient 
subjectively claimed to feel better, her lesions continued 
to progress. She was then referred to an allergist who told 
her to go to the emergency department.
The patient was otherwise healthy and denied a personal 
and family history of autoimmune or dermatologic 
conditions, a history of drug allergies, recent environmental 
exposures, new medications, insect bites, sick contacts, 
and travel. No rash was noted with any of her previous 
three pregnancies. 
DERMATOLOGY
Figure 2. Right thigh. Various stages of healing
Figure 3. Back rash without bullae
Figure 1. Bullae at various stages of healing on the abdomen, and medial and 
anterior thighs.
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OUTCOME AND FOLLOW-UP
After consultation with internal medicine and dermatology, 
the patient was diagnosed with pemphigoid gestationis 
based on history and clinical presentation and started on 
topical clobetasol to intact lesions and oral prednisone 
40mg daily to be tapered once lesions crust over. 
During the remainder of her pregnancy, the patient 
developed edema and hypertension and labor was 
induced. Fortunately, there were no further complications 
with her delivery and the infant was born healthy without 
any detectable lesions. Figures 1-3 show the patient’s 
lesions in various stages of healing, one day after delivery.
DISCUSSION
Pemphigoid gestationis is a rare autoimmune dermatosis 
of pregnancy that affects approximately 1 in 50,000 
pregnant women in the United States2. While its exact 
pathogenesis is not known, it has been postulated to 
result from maternal IgG autoantibodies induced by the 
paternal major histocompatibility complex class II 
antigens in the placenta, the most common being DR-3 
and DR-4. The pathologic antibodies cross the placenta 
and cross-react with proteins in the maternal skin, leading 
to an inflammatory response that ultimately results in the 
formation of bullae3,4. Some studies suggest that estrogen 
and progesterone may also play a role in disease 
pathogenesis, as flare-ups have been demonstrated 
immediately post-partum, during menstruation, and with 
oral contraceptive use3.
Pemphigoid gestationis typically occurs in the second or 
third trimester and initially presents with intensely pruritic, 
erythematous papules or plaques around the umbilicus 
that spreads to the abdomen, back, chest, and extremities 
and eventually form bullae5. Occasionally, as demonstrated 
in this case, vesicles are present initially. In many cases, 
lesions can extend to the soles and palms, but involvement 
of the face and mucosal surfaces is rare. A detailed history 
along with laboratory evaluation which include immuno-
flourescence and histopathology of skin lesions would 
help in coming to a precise diagnosis.
Treatment of this condition is largely symptomatic. The 
current standard of care is topical corticosteroids for 
localized lesions and systemic corticosteroids if the 
topical formulations do not control symptoms. Few case 
reports have suggested intravenous immunoglobulin 
may be an acceptable treatment option if corticosteroids 
cannot be tolerated6 . Because this condition is associated 
with an increased incidence in preterm delivery and low 
birth-weight neonates, it is important that these patients 
deliver in facilities that have a neonatal intensive care unit 
and that are prepared to deal with these complications6. 
Because pemphigoid gestationis is uncommon in the 
United States, it can often be missed or misdiagnosed and 
patients may be sent from specialist to specialist, like the 
patient in this case. It is important to be able to recognize 
this dermatosis to reduce the risk of neonatal complications 
and for appropriate management of the neonate.
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